dexcom inc (DXCM:NASDAQ GS)
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).
Financial Statements for dexcom inc (DXCM)
Year over year, DexCom, Inc. has seen their bottom line shrink from a loss of $44.7M USD to an even larger loss of $54.5M USD despite an increase in revenues from $76.3M USD to $99.9M USD. An increase in the percentage of sales devoted to cost of goods sold from 52.95% to 53.35% was a key component in the falling bottom line in the face of rising revenues.
| Currency in Millions of US Dollars | As of: | Dec 31 2009 | Dec 31 2010 Restated | Dec 31 2011 Restated | Dec 31 2012 | 4 Year Trend |
| Revenues | 29.7 | 48.6 | 76.3 | 99.9 |  | |
| TOTAL REVENUES | 29.7 | 48.6 | 76.3 | 99.9 | | |
| Cost of Goods Sold | 26.0 | 30.2 | 40.4 | 53.3 | | |
| GROSS PROFIT | 3.7 | 18.4 | 35.9 | 46.6 | | |
| Selling General & Admin Expenses, Total | 35.2 | 40.5 | 49.9 | 62.5 | | |
| R&D Expenses | 14.3 | 23.2 | 30.8 | 38.9 | | |
| OTHER OPERATING EXPENSES, TOTAL | 49.5 | 63.7 | 80.7 | 101.4 | | |
| OPERATING INCOME | -45.8 | -45.3 | -44.8 | -54.8 | | |
| Interest Expense | -8.0 | -1.5 | -- | -0.2 | | |
| Interest and Investment Income | 0.4 | 0.1 | 0.1 | 0.1 | | |
| NET INTEREST EXPENSE | -7.7 | -1.4 | 0.1 | -0.1 | | |
| EBT, EXCLUDING UNUSUAL ITEMS | -53.5 | -46.7 | -44.7 | -54.9 | | |
| Merger & Restructuring Charges | -- | -- | -- | -0.3 | | |
| Other Unusual Items, Total | -- | -8.5 | -- | -0.6 | | |
| Other Unusual Items | -- | -8.5 | -- | -0.6 | | |
| EBT, INCLUDING UNUSUAL ITEMS | -53.5 | -55.2 | -44.7 | -55.8 | | |
| Income Tax Expense | -- | -- | -- | -1.3 | | |
| Earnings from Continuing Operations | -53.5 | -55.2 | -44.7 | -54.5 | | |
| NET INCOME | -53.5 | -55.2 | -44.7 | -54.5 | | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | -53.5 | -55.2 | -44.7 | -54.5 | | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | -53.5 | -55.2 | -44.7 | -54.5 | | |
| Recently Viewed | |||
| DXCM:US | $21.18 USD | +1.73 |  |
| Company | Last | Change |
| Abaxis Inc | $45.35 USD | -0.10 |
| Cyberonics Inc | $49.27 USD | +1.05 |
| Endologix Inc | $14.51 USD | +0.49 |
| HeartWare International Inc | $99.19 USD | +3.75 |
| Insulet Corp | $29.66 USD | +0.42 |
| View Industry Companies | ||
Industry Analysis
DXCM
Industry Average
| Valuation | DXCM | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 12.4x |
|
| Price/Book | 18.7x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 12.1x |
|
Post a JobJobs
- San Diego, CA | DexcomPosted: May 16
- San Diego, CA | DexcomPosted: May 16
- San Diego, CA | DexcomPosted: May 13
- San Diego, CA | DexcomPosted: May 16
